<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>风云药谈 | wechat-feeds</title><link>http://Mzg4NzEyNzEzNQ.favicon.privacyhide.com/favicon.ico</link><description>分享、交流、学习</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 04 Mar 2021 20:58:23 +0800</pubDate><image><url>http://Mzg4NzEyNzEzNQ.favicon.privacyhide.com/favicon.ico</url><title>风云药谈 | wechat-feeds</title><link>http://Mzg4NzEyNzEzNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>集采将发生重大变化，续约规则呼之欲出，第五批生物制剂在列？</title><link>https://mp.weixin.qq.com/s/quesYo-XOOxugosZa3gJTg</link><description></description><content:encoded><![CDATA[集采将发生重大变化，续约规则呼之欲出，第五批生物制剂在列？]]></content:encoded><pubDate>Thu, 04 Mar 2021 18:43:02 +0800</pubDate></item><item><title>集采下的招商经理，跳槽还是坚守？转型还是转行？</title><link>https://mp.weixin.qq.com/s/27nQgAWW1PFEBwMYCaf8Hg</link><description></description><content:encoded><![CDATA[集采下的招商经理，跳槽还是坚守？转型还是转行？]]></content:encoded><pubDate>Wed, 03 Mar 2021 23:55:46 +0800</pubDate></item><item><title>重磅：30亿+规模注射用头孢曲松钠首家新增适应症过评，金城金素强势来袭！</title><link>https://mp.weixin.qq.com/s/35z041qu1JV8gBB9AEoX7w</link><description></description><content:encoded><![CDATA[重磅：30亿+规模注射用头孢曲松钠首家新增适应症过评，金城金素强势来袭！]]></content:encoded><pubDate>Tue, 02 Mar 2021 17:40:36 +0800</pubDate></item><item><title>符合第五批集采产品已达79个，注射剂34个！</title><link>https://mp.weixin.qq.com/s/wbb1p3-soitfUqCNK8LGuQ</link><description></description><content:encoded><![CDATA[符合第五批集采产品已达79个，注射剂34个！]]></content:encoded><pubDate>Mon, 01 Mar 2021 22:52:07 +0800</pubDate></item><item><title>集采将走向何方？代理商如何应对与筛选产品？</title><link>https://mp.weixin.qq.com/s/PI9bDsPGYXCjeb_cnP7e_Q</link><description></description><content:encoded><![CDATA[集采将走向何方？代理商如何应对与筛选产品？]]></content:encoded><pubDate>Fri, 26 Feb 2021 16:10:47 +0800</pubDate></item><item><title>药圈精英都是这样炼成的~</title><link>https://mp.weixin.qq.com/s/UPhqAq7AZeylVMD0Z1wu4A</link><description></description><content:encoded><![CDATA[药圈精英都是这样炼成的~]]></content:encoded><pubDate>Fri, 26 Feb 2021 16:10:47 +0800</pubDate></item><item><title>福利：2020版医保3.1执行，新增产品、企业、价格全信息，免费赠送！</title><link>https://mp.weixin.qq.com/s/hOKdPBtEDvGKOsOgpW-8GA</link><description></description><content:encoded><![CDATA[福利：2020版医保3.1执行，新增产品、企业、价格全信息，免费赠送！]]></content:encoded><pubDate>Thu, 25 Feb 2021 15:57:53 +0800</pubDate></item><item><title>药圈精英都是这样炼成的~</title><link>https://mp.weixin.qq.com/s/ky8wZshCNTwYcNhxKO_row</link><description></description><content:encoded><![CDATA[药圈精英都是这样炼成的~]]></content:encoded><pubDate>Thu, 25 Feb 2021 15:57:53 +0800</pubDate></item><item><title>2021年医保局八个大招知多少？应对举措少不了！</title><link>https://mp.weixin.qq.com/s/3uKp8Dt301m_YKwfbcFjCg</link><description></description><content:encoded><![CDATA[2021年医保局八个大招知多少？应对举措少不了！]]></content:encoded><pubDate>Tue, 23 Feb 2021 20:50:27 +0800</pubDate></item><item><title>风云药谈祝大家新年快乐，牛年大吉！</title><link>https://mp.weixin.qq.com/s/whGWL5vjcaVJr1PQ5pl2Ww</link><description></description><content:encoded><![CDATA[风云药谈祝大家新年快乐，牛年大吉！]]></content:encoded><pubDate>Thu, 11 Feb 2021 15:57:17 +0800</pubDate></item><item><title>你莫走~医药人寒假作业来了，每到年底憋大招</title><link>https://mp.weixin.qq.com/s/fCVwjWJknK9iFt-pDc-XxA</link><description></description><content:encoded><![CDATA[你莫走~医药人寒假作业来了，每到年底憋大招]]></content:encoded><pubDate>Tue, 09 Feb 2021 11:44:18 +0800</pubDate></item><item><title>2021“省级带量采”新趋势，影响报价预期，代理商抓住机会！</title><link>https://mp.weixin.qq.com/s/8XCDAbl5SzRCdCfJnGi12g</link><description></description><content:encoded><![CDATA[2021“省级带量采”新趋势，影响报价预期，代理商抓住机会！]]></content:encoded><pubDate>Mon, 08 Feb 2021 15:50:01 +0800</pubDate></item><item><title>独家过评推荐代理产品明细！</title><link>https://mp.weixin.qq.com/s/I5WjQe0MgQsPVDZn3WNIzw</link><description></description><content:encoded><![CDATA[独家过评推荐代理产品明细！]]></content:encoded><pubDate>Mon, 08 Feb 2021 15:50:01 +0800</pubDate></item></channel></rss>